Constance, Germany

Oliver Von Richter

USPTO Granted Patents = 1 


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Oliver Von Richter: Innovator in Gastrointestinal Treatments

Introduction

Oliver Von Richter is a notable inventor based in Constance, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address gastrointestinal disorders. His innovative work has led to the creation of a patent that showcases his expertise and dedication to improving health outcomes.

Latest Patents

Oliver Von Richter holds a patent for "Isotopically substituted proton pump inhibitors." This invention relates to compounds of formula 1 and formula 10, which are designed to treat gastrointestinal disorders. The patent outlines the compositions comprising these compounds and the methods of administering them to patients, highlighting their potential effectiveness in medical treatments.

Career Highlights

Oliver is currently employed at Nycomed GmbH, a company known for its focus on innovative pharmaceutical solutions. His role at Nycomed has allowed him to further his research and development efforts in the field of gastrointestinal treatments. With a total of 1 patent to his name, he has established himself as a valuable contributor to the industry.

Collaborations

Throughout his career, Oliver has collaborated with esteemed colleagues such as Bernhard Kohl and Bernd Müller. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, ultimately benefiting the field of pharmaceuticals.

Conclusion

In summary, Oliver Von Richter is a dedicated inventor whose work in developing isotopically substituted proton pump inhibitors has the potential to significantly impact the treatment of gastrointestinal disorders. His contributions to Nycomed GmbH and collaborations with fellow researchers underscore his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…